FDA advisers support GSK's RSV vaccine : comparemela.com

GSK's vaccine for respiratory syncytial virus won the support of a key panel of U.S. regulatory advisers for use in people 60 and older, as the drugmaker races against Pfizer to bring to market the first vaccine for RSV.

Related Keywords

Japan , London , City Of , United Kingdom , Emma Walmsley , Peggy Webster , Nicholas Geagan , Centers For Disease , Pfizer , Division Of Vaccines , Drug Administration , Products Advisory Committee , Prevention Advisory Committee On Immunization Practices , Related Biological Products Advisory Committee , Chief Executive Officer Emma Walmsley , Related Products , Disease Control , Advisory Committee , Immunization Practices ,